NICE has backed Emgality (galcanezumab) as a once-monthly injection to prevent migraine attacks in people with episodic or chronic migraine who suffer at least four days with a migraine headache ...

The drug provides an alternative to CGRP antagonists delivered by injection ... s Emgality (galcanezumab), and Lundbeck’s Vyepti (eptinezumab), which are also backed for use in migraine prevention.

When giving gluteal injections, it is safest to use the upper outer quadrant. The choice of site for injection must be based on good clinical judgment, using the best evidence available and ...

From pioneering early industrial gripper systems to mastering Metal Injection Moulding, Germany’s Zimmer Group is today a leader in advanced automation and manufacturing technologies. With operations ...